Structural and functional hot spots in cytokine receptors.
The activation of cytokine receptors is a stepwise process that depends on their specific interaction with cognate cytokines, the formation of oligomeric receptor complexes, and the initiation of cytoplasmic phosphorylation events. The recent determination of the structure of extracellular domains of several cytokine receptors allows comparison of their cytokine-binding surfaces. This comparison reveals a common structural framework that supports considerable diversity and adaptability of the binding surfaces that determine both the specificity and the orientation of subunits in the active receptor complex. These regions of the cytokine receptors have been targeted for the development of specific agonists and antagonists. The physical coupling of signaling intermediates to the intracellular domains of their receptors plays a major role in determining biological responses to cytokines. In this review, we focus principally on the receptors for cytokines of the granulocyte-macrophage colony-stimulating factor (GM-CSF) family and, where appropriate, compare them with related cytokine receptors. Several paradigms are beginning to emerge that focus on the ability of the extracellular portion of the cytokine receptor to recognize the appropriate cytokine and on a phosphorylated motif in the intracellular region of the GM-CSF receptor that couples to a specific signaling pathway.
Bagley
C J
CJ
Division of Human Immunology, Hanson Centre for Cancer Research, the Institute of Medical and Veterinary Science, Adelaide, Australia.
Woodcock
J M
JM
Guthridge
M A
MA
Stomski
F C
FC
Lopez
A F
AF
D020816:Amino Acid Motifs; D000818:Animals; D002455:Cell Division; D016207:Cytokines / Q000494:pharmacology; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000187:drug effects / Q000502:physiology; D006412:Hematopoietic Stem Cells / Q000166:cytology / Q000378:metabolism; D006801:Humans; D007377:Interleukin-3 / Q000502:physiology; D015848:Interleukin-5 / Q000502:physiology; D008024:Ligands; D008958:Models, Molecular; D019869:Phosphatidylinositol 3-Kinases / Q000502:physiology; D010766:Phosphorylation; D010768:Phosphoserine / Q000737:chemistry; D019000:Phosphotyrosine / Q000502:physiology; D011487:Protein Conformation; D011499:Protein Processing, Post-Translational; D018121:Receptors, Cytokine / Q000737:chemistry* / Q000187:drug effects / Q000502:physiology; D016187:Receptors, Granulocyte-Macrophage Colony-Stimulating Factor / Q000737:chemistry / Q000187:drug effects / Q000502:physiology; D018123:Receptors, Interleukin / Q000737:chemistry / Q000187:drug effects / Q000502:physiology; D016185:Receptors, Interleukin-3 / Q000737:chemistry / Q000187:drug effects / Q000502:physiology; D053649:Receptors, Interleukin-5; D015398:Signal Transduction; D013329:Structure-Activity Relationship
D016207:Cytokines; D007377:Interleukin-3; D015848:Interleukin-5; D008024:Ligands; D018121:Receptors, Cytokine; D016187:Receptors, Granulocyte-Macrophage Colony-Stimulating Factor; D018123:Receptors, Interleukin; D016185:Receptors, Interleukin-3; D053649:Receptors, Interleukin-5; D010768:Phosphoserine; D019000:Phosphotyrosine; D016178:Granulocyte-Macrophage Colony-Stimulating Factor; D019869:Phosphatidylinositol 3-Kinases